Comparison of Acute Viral Hepatitis Data Quality Using Two Methodologies, 2005-2007

Public Health Reports

Volumn 127, Issue 6, 2012, Pages 591-597

  Iqbal, Kashif ^a   Klevens, R Monina ^a   Jiles, Ruth ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868014371     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491212700609     Document Type: Article

References (13)

1. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis-United States, 2007. MMWR Surveill Summ 2009;58(3):1-27.
2. German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 2001;50(RR-13):1-35.
3. Centers for Disease Control and Prevention (US). Estimates of disease burden from viral hepatitis. Atlanta: CDC; 2008. Also available from: URL: http://www.cdc.gov/hepatitis/PDFs/disease_burden.pdf [cited 2012 Jul 3].
4. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001;7:92-9.
5. Klevens RM, Miller JT, Iqbal K, Thomas A, Rizzo EM, Hanson H, et al. The evolving epidemiology of hepatitis A in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch Intern Med 2010;170:1811-8.
6. Status of state electronic disease surveillance systems-United States,2007. MMWR Morb Mortal Wkly Rep 2009;58(29):804-7.
7. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washingtion: National Academies Press; 2010.
8. ®: Version 9.2. Cary (NC): SAS Institute, Inc.; 2008.
9. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Recomm Rep 1990;39(RR-13):1-43.
10. Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249:1181-5.
11. Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003;52(RR-3):1-13, 15.
12. Klevens RM, Miller J, Vonderwahl C, Speers S, Alelis K, Sweet K, et al. Population-based surveillance for hepatitis C virus, United States, 2006-2007. Emerg Infect Dis 2009;15:1499-502.
13. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-